We are live on
!
Find out more
NA
NewEdge Advisors Portfolio holdings
AUM
$27.7B
1-Year Est. Return
22.98%
This Fund
S&P 500
This Quarter
Est. Return
+6.1%
1 Year Est. Return
+22.98%
3 Year Est. Return
+69.07%
5 Year Est. Return
+86.55%
10 Year Est. Return
+264.51%
AUM
$8.85B
AUM Growth
+$851M
(+11%)
Cap. Flow
+$412M
Cap. Flow
% of AUM
4.65%
Top 10 Holdings %
Top 10 Hldgs %
16.84%
Holding
3,702
New
289
Increased
1,323
Reduced
1,138
Closed
218
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$30.8M |
| 2 |
Unilever
UL
|
+$28.5M |
| 3 |
Comcast
CMCSA
|
+$27.6M |
| 4 |
Illinois Tool Works
ITW
|
+$27.1M |
| 5 |
Mondelez International
MDLZ
|
+$26.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Accenture
ACN
|
+$30.6M |
| 2 |
Abbott
ABT
|
+$28.3M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$27.8M |
| 4 |
Dover
DOV
|
+$27.1M |
| 5 |
State Street Ultra Short Term Bond ETF
ULST
|
+$24.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.26% |
| 2 | Financials | 5.78% |
| 3 | Healthcare | 5.7% |
| 4 | Consumer Discretionary | 4.46% |
| 5 | Industrials | 3.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
951
HealthEquity
HQY
$8.41B
| $840K | 0.01% |
13,298
+332
| +3% | +$19.3K |
|
952
Vanguard Short-Term Treasury ETF
VGSH
$29.3B
| $832K | 0.01% |
14,418
-1,211
| -8% | -$70.5K |
|
953
iShares Morningstar Mid-Cap ETF
IMCB
$1.65B
| $830K | 0.01% |
13,113
-1,104
| -8% | -$66.5K |
|
|
EMD
954
Western Asset Emerging Markets Debt Fund
EMD
$611M
| $829K | 0.01% |
96,200
-900
| -0.9% | -$7.8K |
|
955
Universal Health Services
UHS
$10.2B
| $821K | 0.01% |
5,206
+2,804
| +117% | +$391K |
|
|
MIN
956
Aberdeen Intermediate Income Fund
MIN
$273M
| $821K | 0.01% |
299,600
+6,400
| +2% | +$17.8K |
|
957
Evertec
EVTC
$1.88B
| $819K | 0.01% |
22,251
+632
| +3% | +$21.9K |
|
958
SPS Commerce
SPSC
$2.64B
| $815K | 0.01% |
4,242
+4,207
| +12,020% | +$679K |
|
959
Owens Corning
OC
$11.2B
| $813K | 0.01% |
6,231
-177
| -3% | -$19.4K |
|
960
Moderna
MRNA
$21.8B
| $813K | 0.01% |
6,691
-2,179
| -25% | -$291K |
|
961
FT Vest US Equity Buffer ETF July
FJUL
$1.21B
| $809K | 0.01% |
20,755
-550
| -3% | -$20.3K |
|
962
Invesco Bloomberg Pricing Power ETF
POWA
$178M
| $808K | 0.01% |
11,667
-446
| -4% | -$30K |
|
|
PCF
963
High Income Securities Fund
PCF
$98.8M
| $805K | 0.01% |
124,200
+1,900
| +2% | +$12K |
|
964
FT Vest Fund of Deep Buffer ETFs
BUFD
$1.94B
| $804K | 0.01% |
37,332
-6,215
| -14% | -$129K |
|
965
iShares MSCI ACWI ETF
ACWI
$32.9B
| $804K | 0.01% |
8,375
+667
| +9% | +$61.9K |
|
966
Molina Healthcare
MOH
$10.2B
| $803K | 0.01% |
+2,665
| New | +$766K |
|
967
Invesco BuyBack Achievers ETF
PKW
$1.72B
| $802K | 0.01% |
8,966
+22
| +0.2% | +$1.88K |
|
968
FirstCash
FCFS
$8.85B
| $802K | 0.01% |
8,590
+3,025
| +54% | +$296K |
|
969
Invesco High Income Trust II
VLT
$64.9M
| $799K | 0.01% |
76,109
+1,934
| +3% | +$20.1K |
|
970
Exelon
EXC
$47.2B
| $799K | 0.01% |
19,604
+1,193
| +6% | +$49.3K |
|
|
AGD
971
abrdn Global Dynamic Dividend Fund
AGD
$316M
| $797K | 0.01% |
83,569
+1,884
| +2% | +$17.7K |
|
|
GRMN
972
Garmin
GRMN
$56.7B
| $797K | 0.01% |
7,643
+4,492
| +143% | +$459K |
|
973
Vanguard Industrials ETF
VIS
$8.1B
| $794K | 0.01% |
3,865
-544
| -12% | -$104K |
|
974
iShares MSCI Brazil ETF
EWZ
$9.28B
| $792K | 0.01% |
24,420
+23,850
| +4,184% | +$710K |
|
975
iMGP DBi Managed Futures Strategy ETF
DBMF
$3.98B
| $791K | 0.01% |
28,645
-4,224
| -13% | -$113K |
|
Similar funds
FDCDDQ
TWC
N
PCH
PAM
WP
NewEdge Advisors's Q2 2023 Portfolio in Review
As of Q2 2023, NewEdge Advisors held 3,702 positions worth $8.85B, up 11% from $8B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
NewEdge Advisors deployed $412M of net new capital in Q2 2023, opening 289 new positions and adding to 1,323 existing holdings. Its largest new stake was Franklin International Core Dividend Tilt Index ETF: 317,686 shares worth $9.29M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 12% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Accenture, an estimated $30.6M trimmed.
- NewEdge Advisors's largest Q2 2023 buy was Franklin International Core Dividend Tilt Index ETF: 317,686 shares worth $9.29M.
- NewEdge Advisors added most to AbbVie in Q2 2023, an estimated $30.8M increase.
- NewEdge Advisors's biggest Q2 2023 reduction was Accenture, cutting an estimated $30.6M.
- NewEdge Advisors fully exited Quadratic Deflation ETF in Q2 2023, selling an estimated $3.13M.
- NewEdge Advisors's ten largest holdings make up 17% of its $8.85B portfolio in Q2 2023.
- NewEdge Advisors opened 289 new positions and closed 218 in Q2 2023.
- NewEdge Advisors's portfolio value rose 11% quarter-over-quarter to $8.85B.
Based on NewEdge Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.